Riskpilot← Back to searchSign inGet full accessAttends AB
ABActiveOrg 5567577258Järnvägsgatan 4Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200810-19 employees
Revenue 2024
SEK 321,7M
+8% vs 2023
EBITDA margin
0.8%
-3% vs 2023
Equity ratio
14.6%
Financial strength
Net profit 2024
SEK -69K
-3% vs 2023
| Revenue | SEK 321,7M | +8% |
| EBITDA | SEK 2,5M | -3% |
| Net profit | SEK -69K | -3% |
| Total assets | SEK 46,7M | +22% |
| Equity | SEK 6,8M | -1% |
| Employees | — | — |
Legal name
Attends AB
Org number
5567577258
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9 maj 2008
Share capital
SEK 100 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Föremålet för bolagets verksamhet är inom Europa handel med hjälpmedel i form av engångsartiklar för inkontinens för användning inom hälso- och sjukvård och därmed förenlig verksamhet.
Address
Järnvägsgatan 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 163 325 | 187 287 | 206 864 | 227 381 | 218 342 | 256 337 | 299 172 | 321 664 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 1 518 | 1 678 | 1 646 | 2 023 | 1 924 | 2 037 | 2 304 | 2 453 | 2 566 | 2 496 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 518 | 1 678 | 1 646 | 2 023 | 1 924 | 2 037 | 2 304 | 2 453 | 2 566 | 2 496 |
| Net financials | −17 | 3 | −7 | −9 | −2 | 42 | −51 | −259 | 29 | −598 |
| Profit before tax | −94 | −78 | −95 | −172 | −118 | −10 | 34 | 52 | −64 | −69 |
| Tax | −0 | −1 | −0 | −0 | −0 | −11 | −19 | −9 | −3 | −0 |
| Net profit | −94 | −79 | −95 | −172 | −118 | −21 | 15 | 43 | −67 | −69 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 25 102 | 23 971 | 24 168 | 28 827 | 35 570 | 42 188 | 35 568 | 37 554 | 38 242 | 46 687 |
| Equity | 7 392 | 7 312 | 7 217 | 7 045 | 6 927 | 6 906 | 6 921 | 6 964 | 6 898 | 6 828 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 17 710 | 16 659 | 16 951 | 21 782 | 28 642 | 35 282 | 28 647 | 30 590 | 31 344 | 39 859 |
| Total debt | 17 710 | 16 659 | 16 951 | 21 782 | 28 642 | 35 282 | 28 647 | 30 590 | 31 344 | 39 859 |
EBITDA margin
0.8%
This company
15.8%
Market median
-95% vs market
20152024
Equity ratio
14.6%
This company
38.2%
Market median
-62% vs market
20152024
Return on equity
-1.0%
This company
18.4%
Market median
-105% vs market
20152024
Net profit margin
-0.0%
This company
8.1%
Market median
-100% vs market
20152024
Asset turnover
6.89×
This company
1.12×
Market median
+515% vs market
20152024
Debt / equity
5.84×
This company
0.62×
Market median
-842% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PJ Chief Auditor | Chief Auditor | 2021 | — | — |
ML Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Attends Healthcare Holdings AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DPC Swedish Holdings ABAttindas Hygiene Partners ABAttends Healthcare Holdings AB
Attends AB (this company)Board members of Attends AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Johan Engstam | Chief Auditor | 0 companies |
| Malin Lanneborn | Chief Auditor | 0 companies |
| Mattias Robert Wilner | Chairman | 0 companies |
| Trevor Kenneth Zieseniss | Board of Directors | 0 companies |
| Emilio Barta Perez | Board of Directors | 0 companies |
| Anna Clara Södergren | Board of Directors | 0 companies |